Stay updated on TAK-659 in AML Clinical Trial

Sign up to get notified when there's something new on the TAK-659 in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAK-659 in AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A sitewide NIH notice was added, linking to transition updates and explaining that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.” The study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T14:07:55.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-18T14:27:48.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The revision identifier in the footer changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T15:11:41.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record NCT02323113, blocking access to the study details.
    Difference
    20%
    Check dated 2026-09-20T20:33:41.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor software update rather than content changes.
    Difference
    0.0%
    Check dated 2026-08-30T17:42:34.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5, indicating a small update to the page’s revision history rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-08-09T12:27:12.000Z thumbnail image

Stay in the know with updates to TAK-659 in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAK-659 in AML Clinical Trial page.